Gnosis Expands U.S. Marketing Efforts

DESIO, Italy—As U.S. consumers look for natural ways to support heart health, Gnosis is expanding its marketing efforts into the United States, promoting its cardiovascular health ingredients to nutraceutical marketers. Among the offers are Biokyn™ natural nattokinase, VitamK7™ natural vitamin K2 and HI-QTEN™ highly bioavailable coenzyme Q10 (CoQ10). The company has conducted clinical studies into the efficacy and activity of its ingredients in the area of heart health, and has ongoing studies exploring potential applications.

“Our goal is to be pro-active and anticipate market and customer needs,” said Paolo Malesani, Ph.D., director of marketing and sales, Gnosis. “With our current and future portfolio of cardiovascular health ingredients, we offer manufacturers proprietary ingredients with significant market growth opportunity.”

The company operates two GMP (good manufacturing practice) compliance manufacturing and R&D facilities, and has a primary production focus on ingredients produced through natural fermentation processes. As part of its expanded efforts in the United States, Gnosis is exhibiting at Natural Products Expo West (Booth #604) and redesigned its Web site, adding a section that allows formulators to search products by health indication.